Focus Molecular Diagnostics
Focus Molecular Diagnostics Molecular diagno
Challenges and State of the Art: The advanced stage patient
Challenges and State of the Art: The advanced st
Challenges and State of the Art: The intermediate stage patient
Challenges and State of the Art: The intermediat
Challenges and State of the Art: The early stage patient
Challenges and State of the Art: The early stage
Preface – Preceptorship Cologne
Preface – Preceptorship Cologne Dear Colleag
EGFR和ALK靶向治疗：当下与将来
EGFR和ALK靶向治疗：当下与将来 用于晚期或转移性肺癌的化疗发展缓慢，在1948年至21世纪初期间
免疫疗法：新兴的治疗范例
免疫疗法：新兴的治疗范例 15至20年前分子靶向药物的引入标志着一个新时代的开始。今天，免疫检查点抑制
序言
序言 周彩存，MD, PhD 上海市肺科医院 中国上海同济大学肿瘤研究所所长 亲爱的同事们， 20
EGFR- and ALK-targeted treatment: present and future
EGFR- and ALK-targeted treatment: present and fu
Immunotherapy: the emerging paradigm of cure
Immunotherapy: the emerging paradigm of cure
